S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Valeant Nears Deal to Buy Salix (2015/2/21)|
|Valeant Approved to Buy Dendreon Assets for $495 Million (2015/2/20)|
|Valeant to Buy Prostate-Cancer Drug From Dendreon (2015/1/29)|
|Valeant soars on plan to buy Salix for $10 billion (2015/2/23)|
|UPDATE: Valeant pops on Salix deal; Ocwen, Cooper Tire among big losers (2015/2/23)|
|UPDATE: Valeant, Ocwen pop on deals; Transocean dips on downgrade (2015/2/23)|
|Robbins Arroyo LLP: Acquisition of Salix Pharmaceuticals Ltd. (SLXP) by Valeant Pharmaceuticals International, Inc. (VRX) May Not Be in Shareholders' Best Interests (2015/2/23)|
|UPDATE - INVESTOR ALERT: Levi & Korsinsky, LLP Commences an Investigation of the Board of Directors of SALIX PHARMACEUTICALS, LTD. In Connection With the Fairness of the SALE OF THE COMPANY TO VALEANT PHARMACEUTICALS INTERNATIONAL, INC. -- SLXP (2015/2/24)|
|Salix Pharmaceuticals, Ltd. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Valeant Pharmaceuticals International, Inc. (2015/2/23)|
|Valeant Pharmaceuticals Reports Fourth Quarter And Full Year 2014 Financial Results (2015/2/22)|
Click above to view more mutual fund data and stats for vrx - Valeant Pharmaceuticals International Inc.